Browse result page of SalivaDB
This is the result page of the browse module of SalivaDB. This page gives the information about the query submitted by the user as per the browse category. Further details of the entries can be seen by clicking on the SAL_ID. Further the user can sort the entries on the basis of various fields by clicking on the respective headers. The user can also download the results in various formats.
 |
Tabular representation:
| SAL_ID | Biomarker Name | Biomarker Type | Analysis Method | Collection Site | Disease/Condition Category | Disease/Condition | Disease/Condition Subtype | Fold Change | Regulation | Exosomal Origin | Organism | PMID | YOP | External Links | Biomarker Category | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAL_10285 | Antileukoproteinase | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P03973 | Protein| SAL_10286 | ASVD | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P01833 | Protein | SAL_10287 | Cystatin A | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P01040 | Protein | SAL_10288 | Cystatin B Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P04080 | Protein | SAL_10289 | Cystatin C | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P01034 | Protein | SAL_10290 | Cystatin S1 di-ox | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01036 | Protein | SAL_10291 | Cystatin S1 mono-ox | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01036 | Protein | SAL_10292 | Cystatin S1-ox Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01036 | Protein | SAL_10293 | Cystatin SA | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P09228 | Protein | SAL_10294 | Cystatin SA Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P09228 | Protein | SAL_10295 | Cystatin SN | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P01037 | Protein | SAL_10296 | Cystatin SN Des1-4 | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P01037 | Protein | SAL_10297 | Cystatin SN di-ox | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01037 | Protein | SAL_10298 | Cystatin SN mono-ox | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01037 | Protein | SAL_10299 | Cystatin SN-ox Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P01037 | Protein | SAL_10300 | Peptide P-C Fr. Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P02810 | Protein | SAL_10301 | Peptide P-C Fr. 1-14 | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P02810 | Protein | SAL_10302 | Peptide P-C Fr. 26-44 | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P02810 | Protein | SAL_10303 | Peptide P-C Fr. 36-44 | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P02810 | Protein | SAL_10304 | PIP pyro (dHex-HexNAc) | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P12273 | Protein | SAL_10305 | PIP pyro (HexNAc) | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P12273 | Protein | SAL_10306 | PIP Tot | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | A0A0A0MSP5 | Protein | SAL_10307 | S100A7(E27_D) | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P31151 | Protein | SAL_10308 | S100A8-SNO | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P05109 | Protein | SAL_10309 | Statherin 1P | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Downregulated | NA | Homo sapiens | 30086402 | 2018 | P02808 | Protein | SAL_10310 | Statherin SV1 | NA | MS | Whole Saliva | Neurological Disorder | Multiple Sclerosis | NA | NA | Upregulated | NA | Homo sapiens | 30086402 | 2018 | P02808 | Protein | SAL_10367 | Salivary Abeta-42 | NA | ELISA | Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | NA | NA | Homo sapiens | 30257642 | 2018 | P05067 | Protein | SAL_11071 | alpha-synuclein | Diagnostic | Electrochemiluminescence (ECL) assays | Saliva | Neurological Disorder | ParkinsonÕs disease | NA | >10 | Upregulated | Exosomal | Homo sapiens | 30579996 | 2018 | P37840 | Protein | SAL_11091 | Alpha-synuclein | Diagnostic | ELISA | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | NA | NA | Homo sapiens | 30796010 | 2019 | P37840 | Protein | SAL_11877 | Ab40 | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P05067 | Protein | SAL_11878 | Ab42 | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P05067 | Protein | SAL_11879 | Adenosine deaminase | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | Q6DHV7 | Protein | SAL_11880 | C-reactive protein | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P02741 | Protein | SAL_11881 | Complement C4 | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P0C0L5, P0C0L4 | Protein | SAL_11882 | Haptoglobin | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P00738 | Protein | SAL_11883 | MIP-4 | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P55774 | Protein | SAL_11884 | P-tau181 | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P10636 | Protein | SAL_11885 | PEDF | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P36955 | Protein | SAL_11886 | SAP | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P0DJI8 | Protein | SAL_11887 | T-tau | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P10636 | Protein | SAL_11888 | alpha-1 Antitrypsin | Diagnostic | Biochemical analysis | Whole Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | Upregulated | NA | Homo sapiens | 31989369 | 2020 | P01009 | Protein | SAL_11987 | Salivary lactoferrin | NA | ELISA + Amyloid-PETscan | Saliva | Neurological Disorder | AlzheimerÕs disease | NA | NA | downregulated | NA | Homo sapiens | 32586758 | 2020 | P02788 | Protein | SAL_12575 | Alpha-1B-glycoprotein (Alpha-1-B glycoprotein) | NA | Western Blot in SDS PAGE | Saliva | Neurological Disorder | Alzheimer's Disease | NA | NA | NA | NA | Homo sapiens | 12809550 | 2003 | P04217 | Protein | SAL_15203 | Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) | NA | Western Blot, In-Gel digestion, Mass spectrometry, Immunoprecipitation,Luminex Assay | Whole Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Downregulated | NA | Homo sapiens | 21349902 | 2011 | P37840 | Protein | SAL_15204 | Protein deglycase DJ-1 (DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (Oncogene DJ1) (Parkinson disease protein 7) | NA | Western Blot, In-Gel digestion, Mass spectrometry, Immunoprecipitation,Luminex Assay | Whole Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 21349902 | 2011 | Q99497 | Protein | SAL_16431 | 5-Aminopentanoate | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Alzheimer's Disease | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 138 | Metabolite | SAL_16432 | Acetone | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Alzheimer's Disease | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 180 | Metabolite | SAL_16433 | Acetone | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Mild Cognitive Impairment (MCI) | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 180 | Metabolite | SAL_16434 | Creatinine | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Alzheimer's Disease | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 588 | Metabolite | SAL_16435 | Galactose | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Mild Cognitive Impairment (MCI) | NA | NA | Decrease | NA | Homo sapiens | 28453477 | 2017 | 6036 | Metabolite | SAL_16436 | Imidazole | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Mild Cognitive Impairment (MCI) | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 795 | Metabolite | SAL_16437 | Propionate | Diagnostic | H-NMR | Supernatant Saliva | Neurological Disorder | Alzheimer's Disease | NA | NA | Increase | NA | Homo sapiens | 28453477 | 2017 | 104745 | Metabolite | SAL_16438 | Salivary glutamate | Diagnostic | NA | Saliva | Neurological Disorder | migraine | NA | NA | Upregulated | NA | Homo sapiens | 29126354 | 2017 | 33032 | Metabolite | SAL_16681 | Acetate | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 175 | Metabolite | SAL_16682 | Acetoacetate | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6971017 | Metabolite | SAL_16683 | Acetoin | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 179 | Metabolite | SAL_16684 | Alanine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 5950 | Metabolite | SAL_16685 | Fucose | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 17106 | Metabolite | SAL_16686 | GABA | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 119 | Metabolite | SAL_16687 | Glycine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 750 | Metabolite | SAL_16688 | Histidine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6274 | Metabolite | SAL_16689 | Isoleucine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6306 | Metabolite | SAL_16690 | N-acetylglutamate | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 70914 | Metabolite | SAL_16691 | Phenylalanine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6140 | Metabolite | SAL_16692 | Propionate | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 104745 | Metabolite | SAL_16693 | Taurine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 1123 | Metabolite | SAL_16694 | TMAO | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 1145 | Metabolite | SAL_16695 | Tyrosine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6057 | Metabolite | SAL_16696 | Valine | NA | NMR | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Upregulated | NA | Homo sapiens | 31897951 | 2020 | 6287 | Metabolite | SAL_16815 | Salivary caffeine | NA | HPLC | Saliva | Neurological Disorder | Parkinson's Disease | NA | NA | Downregulated | NA | Homo sapiens | 33972579 | 2021 | 2519 | Metabolite | SAL_17838 | 2-Hydroxybutyric acid [HMDB0000008] | NA | NA | Saliva | Neurological Disorder | Alzheimer's disease | NA | 7.26 +/- 4.47 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 11266 | Metabolite | SAL_17839 | 2-Hydroxybutyric acid [HMDB0000008] | NA | NA | Saliva | Neurological Disorder | Frontotemporal lobe dementia | NA | 7.30 +/- 1.32 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 11266 | Metabolite | SAL_17840 | 2-Hydroxybutyric acid [HMDB0000008] | NA | NA | Saliva | Neurological Disorder | Lewy body disease | NA | 8.12 +/- 5.32 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 11266 | Metabolite | SAL_17853 | 3-Hydroxybutyric acid [HMDB0000011] | NA | NA | Saliva | Neurological Disorder | Alzheimer's disease | NA | 6.62 +/- 0.72 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 441 | Metabolite | SAL_17854 | 3-Hydroxybutyric acid [HMDB0000011] | NA | NA | Saliva | Neurological Disorder | Frontotemporal lobe dementia | NA | 6.37 +/- 1.75 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 441 | Metabolite | SAL_17855 | 3-Hydroxybutyric acid [HMDB0000011] | NA | NA | Saliva | Neurological Disorder | Lewy body disease | NA | 24.25 +/- 32.08 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 441 | Metabolite | SAL_17869 | 3-Phosphoglyceric acid [HMDB0000807] | NA | NA | Saliva | Neurological Disorder | Alzheimer's disease | NA | 6.07 +/- 3.08 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 439183 | Metabolite | SAL_17870 | 3-Phosphoglyceric acid [HMDB0000807] | NA | NA | Saliva | Neurological Disorder | Frontotemporal lobe dementia | NA | 7.73 +/- 6.31 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 439183 | Metabolite | SAL_17871 | 3-Phosphoglyceric acid [HMDB0000807] | NA | NA | Saliva | Neurological Disorder | Lewy body disease | NA | 8.40 +/- 9.51 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 439183 | Metabolite | SAL_17905 | Adenine [HMDB0000034] | NA | NA | Saliva | Neurological Disorder | Alzheimer's disease | NA | 1.03 +/- 0.73 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 190 | Metabolite | SAL_17906 | Adenine [HMDB0000034] | NA | NA | Saliva | Neurological Disorder | Frontotemporal lobe dementia | NA | 0.87 +/- 0.78 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 190 | Metabolite | SAL_17907 | Adenine [HMDB0000034] | NA | NA | Saliva | Neurological Disorder | Lewy body disease | NA | 0.37 +/- 0.21 uM | NA | NA | Homo sapiens | 23857558 | 2013 | 190 | Metabolite | |